-+ 0.00%
-+ 0.00%
-+ 0.00%

Sanofi Reports Durable Efficacy for Duvakitug in Ulcerative Colitis and Crohn’s Disease Phase 2b Trial

Reuters·02/17/2026 11:00:18

Please log in to view news